ADC Therapeutics S.A.

NYSE: ADCT · Real-Time Price · USD
3.13
-0.06 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
3.13
-0.04%
After-hours: Aug 15, 2025, 06:42 PM EDT

ADC Therapeutics S.A. Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-157.85M -240.05M -155.8M -230.03M
Depreciation & Amortization
3.28M 3.27M 2.33M 2.63M
Stock-Based Compensation
6.57M 13.49M 49.32M 60.48M
Other Working Capital
321K -8.3M 18.4M 6.16M
Other Non-Cash Items
20.34M 23.23M 1.07M -24.7M
Deferred Income Tax
n/a 37.1M -708K -21.48M
Change in Working Capital
3.83M 44.27M -33.01M -20.28M
Operating Cash Flow
-123.83M -118.69M -136.79M -233.38M
Capital Expenditures
-867K -3.22M -2.3M -6.38M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -210K -297K
Investing Cash Flow
-867K -3.22M -2.51M -6.67M
Debt Repayment
n/a n/a -2.71M 48.61M
Common Stock Repurchased
n/a n/a -221K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
36.55M 73.88M -4.32M 218.78M
Financial Cash Flow
97.05M 73.88M -593K 267.39M
Net Cash Flow
-27.73M -47.84M -140.1M 27.35M
Free Cash Flow
-124.7M -121.9M -139.09M -239.75M